(Tyr0)-Fibrinopeptide A (human) is a modified version of fibrinopeptide A, incorporating a tyrosine residue at the N-terminus for easier labeling and tracking in biochemical assays. This peptide fragment is released during fibrinogen cleavage and plays a role in clot formation. Researchers use it to investigate thrombin activity and fibrinogen interactions in coagulation studies.
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More